Our details demonstrate that CK18 is constantly expressed in numerous epithelial cancers, In particular adenocarcinomas. the two loss of CK18 expression in cancers derived from CK18 positive precursor cells and neo-expression in malignancies derived from CK18 favourable precursors are generally linked to unfavorable tumor phenotype and illness resu